2mbe

From Proteopedia

(Difference between revisions)

Revision as of 06:30, 2 March 2023

Backbone 1H and 15N Chemical Shift Assignments for the first domain of FAT10

Structural highlights

2mbe is a 1 chain structure with sequence from Homo sapiens. Full experimental information is available from OCA. For a guided tour on the structure components use FirstGlance.
Resources:	FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

UBD_HUMAN Ubiquitin-like protein modifier which can be covalently attached to target protein and subsequently leads to their degradation by the 26S proteasome, in a NUB1L-dependent manner. Probably functions as a survival factor. Conjugation ability activated by UBA6. Promotes the expression of the proteasome subunit beta type-9 (PSMB9/LMP2). Regulates TNF-alpha-induced and LPS-mediated activation of the central mediator of innate immunity NF-kappa-B by promoting TNF-alpha-mediated proteasomal degradation of ubiquitinated-I-kappa-B-alpha. Required for TNF-alpha-induced p65 nuclear translocation in renal tubular epithelial cells (RTECs). May be involved in dendritic cell (DC) maturation, the process by which immature dendritic cells differentiate into fully competent antigen-presenting cells that initiate T-cell responses. Mediates mitotic non-disjunction and chromosome instability, in long-term in vitro culture and cancers, by abbreviating mitotic phase and impairing the kinetochore localization of MAD2L1 during the prometaphase stage of the cell cycle. May be involved in the formation of aggresomes when proteasome is saturated or impaired. Mediates apoptosis in a caspase-dependent manner, especially in renal epithelium and tubular cells during renal diseases such as polycystic kidney disease and Human immunodeficiency virus (HIV)-associated nephropathy (HIVAN).^[1] ^[2] ^[3] ^[4] ^[5] ^[6] ^[7] ^[8] ^[9] ^[10]

Publication Abstract from PubMed

FAT10 (HLA-F-adjacent transcript 10) is a ubiquitin-like modifier that is commonly overexpressed in various tumors. It was found to play a role in mitotic regulation through its interaction with mitotic arrest-deficient 2 (MAD2). Overexpression of FAT10 promotes tumor growth and malignancy. Here, we identified the MAD2-binding interface of FAT10 to be located on its first ubiquitin-like domain whose NMR structure thus was determined. We further proceeded to demonstrate that disruption of the FAT10-MAD2 interaction through mutation of specific MAD2-binding residues did not interfere with the interaction of FAT10 with its other known interacting partners. Significantly, ablation of the FAT10-MAD2 interaction dramatically limited the promalignant capacity of FAT10, including promoting tumor growth in vivo and inducing aneuploidy, proliferation, migration, invasion, and resistance to apoptosis in vitro. Our results strongly suggest that the interaction of FAT10 with MAD2 is a key mechanism underlying the promalignant property of FAT10 and offer prospects for the development of anticancer strategies.

Disruption of FAT10-MAD2 binding inhibits tumor progression.,Theng SS, Wang W, Mah WC, Chan C, Zhuo J, Gao Y, Qin H, Lim L, Chong SS, Song J, Lee CG Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):E5282-91. doi:, 10.1073/pnas.1403383111. Epub 2014 Nov 24. PMID:25422469^[11]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

↑ Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol. 2005 May;25(9):3483-91. PMID:15831455 doi:http://dx.doi.org/10.1128/MCB.25.9.3483-3491.2005
↑ Ross MJ, Wosnitzer MS, Ross MD, Granelli B, Gusella GL, Husain M, Kaufman L, Vasievich M, D'Agati VD, Wilson PD, Klotman ME, Klotman PE. Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J Am Soc Nephrol. 2006 Apr;17(4):996-1004. Epub 2006 Feb 22. PMID:16495380 doi:http://dx.doi.org/10.1681/ASN.2005070692
↑ Ren J, Kan A, Leong SH, Ooi LL, Jeang KT, Chong SS, Kon OL, Lee CG. FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem. 2006 Apr 21;281(16):11413-21. Epub 2006 Feb 22. PMID:16495226 doi:http://dx.doi.org/10.1074/jbc.M507218200
↑ Chiu YH, Sun Q, Chen ZJ. E1-L2 activates both ubiquitin and FAT10. Mol Cell. 2007 Sep 21;27(6):1014-23. PMID:17889673 doi:http://dx.doi.org/10.1016/j.molcel.2007.08.020
↑ Kalveram B, Schmidtke G, Groettrup M. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J Cell Sci. 2008 Dec 15;121(Pt 24):4079-88. doi: 10.1242/jcs.035006. Epub 2008, Nov 25. PMID:19033385 doi:http://dx.doi.org/10.1242/jcs.035006
↑ Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, Autschbach F, Schirmacher P, Breuhahn K, Groettrup M. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene. 2008 Oct 9;27(46):6068-74. doi: 10.1038/onc.2008.201. Epub 2008 Jun 23. PMID:18574467 doi:http://dx.doi.org/10.1038/onc.2008.201
↑ Schmidtke G, Kalveram B, Groettrup M. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L. FEBS Lett. 2009 Feb 4;583(3):591-4. doi: 10.1016/j.febslet.2009.01.006. Epub 2009, Jan 21. PMID:19166848 doi:http://dx.doi.org/10.1016/j.febslet.2009.01.006
↑ Ebstein F, Lange N, Urban S, Seifert U, Kruger E, Kloetzel PM. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int J Biochem Cell Biol. 2009 May;41(5):1205-15. doi:, 10.1016/j.biocel.2008.10.023. Epub 2008 Nov 5. PMID:19028597 doi:http://dx.doi.org/10.1016/j.biocel.2008.10.023
↑ Snyder A, Alsauskas Z, Gong P, Rosenstiel PE, Klotman ME, Klotman PE, Ross MJ. FAT10: a novel mediator of Vpr-induced apoptosis in human immunodeficiency virus-associated nephropathy. J Virol. 2009 Nov;83(22):11983-8. doi: 10.1128/JVI.00034-09. Epub 2009 Sep 2. PMID:19726511 doi:http://dx.doi.org/10.1128/JVI.00034-09
↑ Gong P, Canaan A, Wang B, Leventhal J, Snyder A, Nair V, Cohen CD, Kretzler M, D'Agati V, Weissman S, Ross MJ. The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol. 2010 Feb;21(2):316-26. doi: 10.1681/ASN.2009050479. Epub 2009, Dec 3. PMID:19959714 doi:http://dx.doi.org/10.1681/ASN.2009050479
↑ Theng SS, Wang W, Mah WC, Chan C, Zhuo J, Gao Y, Qin H, Lim L, Chong SS, Song J, Lee CG. Disruption of FAT10-MAD2 binding inhibits tumor progression. Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):E5282-91. doi:, 10.1073/pnas.1403383111. Epub 2014 Nov 24. PMID:25422469 doi:http://dx.doi.org/10.1073/pnas.1403383111

1 Structural highlights
2 Function
3 Publication Abstract from PubMed
4 References

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2mbe"

Categories: Homo sapiens | Large Structures | Lim L | Qin H | Wang W

@@ Line 1: / Line 1: @@
 ==Backbone 1H and 15N Chemical Shift Assignments for the first domain of FAT10==
-<StructureSection load='2mbe' size='340' side='right'caption='[[2mbe]], [[NMR_Ensembles_of_Models | 8 NMR models]]' scene=''>
+<StructureSection load='2mbe' size='340' side='right'caption='[[2mbe]]' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[2mbe]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MBE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2MBE FirstGlance]. <br>
+<table><tr><td colspan='2'>[[2mbe]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MBE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2MBE FirstGlance]. <br>
-</td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">UBD, FAT10 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
+</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2mbe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mbe OCA], [https://pdbe.org/2mbe PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2mbe RCSB], [https://www.ebi.ac.uk/pdbsum/2mbe PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2mbe ProSAT]</span></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2mbe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mbe OCA], [https://pdbe.org/2mbe PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2mbe RCSB], [https://www.ebi.ac.uk/pdbsum/2mbe PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2mbe ProSAT]</span></td></tr>
 </table>
 == Function ==
-[[https://www.uniprot.org/uniprot/UBD_HUMAN UBD_HUMAN]] Ubiquitin-like protein modifier which can be covalently attached to target protein and subsequently leads to their degradation by the 26S proteasome, in a NUB1L-dependent manner. Probably functions as a survival factor. Conjugation ability activated by UBA6. Promotes the expression of the proteasome subunit beta type-9 (PSMB9/LMP2). Regulates TNF-alpha-induced and LPS-mediated activation of the central mediator of innate immunity NF-kappa-B by promoting TNF-alpha-mediated proteasomal degradation of ubiquitinated-I-kappa-B-alpha. Required for TNF-alpha-induced p65 nuclear translocation in renal tubular epithelial cells (RTECs). May be involved in dendritic cell (DC) maturation, the process by which immature dendritic cells differentiate into fully competent antigen-presenting cells that initiate T-cell responses. Mediates mitotic non-disjunction and chromosome instability, in long-term in vitro culture and cancers, by abbreviating mitotic phase and impairing the kinetochore localization of MAD2L1 during the prometaphase stage of the cell cycle. May be involved in the formation of aggresomes when proteasome is saturated or impaired. Mediates apoptosis in a caspase-dependent manner, especially in renal epithelium and tubular cells during renal diseases such as polycystic kidney disease and Human immunodeficiency virus (HIV)-associated nephropathy (HIVAN).<ref>PMID:15831455</ref> <ref>PMID:16495380</ref> <ref>PMID:16495226</ref> <ref>PMID:17889673</ref> <ref>PMID:19033385</ref> <ref>PMID:18574467</ref> <ref>PMID:19166848</ref> <ref>PMID:19028597</ref> <ref>PMID:19726511</ref> <ref>PMID:19959714</ref>
+[https://www.uniprot.org/uniprot/UBD_HUMAN UBD_HUMAN] Ubiquitin-like protein modifier which can be covalently attached to target protein and subsequently leads to their degradation by the 26S proteasome, in a NUB1L-dependent manner. Probably functions as a survival factor. Conjugation ability activated by UBA6. Promotes the expression of the proteasome subunit beta type-9 (PSMB9/LMP2). Regulates TNF-alpha-induced and LPS-mediated activation of the central mediator of innate immunity NF-kappa-B by promoting TNF-alpha-mediated proteasomal degradation of ubiquitinated-I-kappa-B-alpha. Required for TNF-alpha-induced p65 nuclear translocation in renal tubular epithelial cells (RTECs). May be involved in dendritic cell (DC) maturation, the process by which immature dendritic cells differentiate into fully competent antigen-presenting cells that initiate T-cell responses. Mediates mitotic non-disjunction and chromosome instability, in long-term in vitro culture and cancers, by abbreviating mitotic phase and impairing the kinetochore localization of MAD2L1 during the prometaphase stage of the cell cycle. May be involved in the formation of aggresomes when proteasome is saturated or impaired. Mediates apoptosis in a caspase-dependent manner, especially in renal epithelium and tubular cells during renal diseases such as polycystic kidney disease and Human immunodeficiency virus (HIV)-associated nephropathy (HIVAN).<ref>PMID:15831455</ref> <ref>PMID:16495380</ref> <ref>PMID:16495226</ref> <ref>PMID:17889673</ref> <ref>PMID:19033385</ref> <ref>PMID:18574467</ref> <ref>PMID:19166848</ref> <ref>PMID:19028597</ref> <ref>PMID:19726511</ref> <ref>PMID:19959714</ref>
 <div style="background-color:#fffaf0;">
 == Publication Abstract from PubMed ==
@@ Line 22: / Line 21: @@
 __TOC__
 </StructureSection>
-[[Category: Human]]
+[[Category: Homo sapiens]]
 [[Category: Large Structures]]
-[[Category: Lim, L]]
+[[Category: Lim L]]
-[[Category: Qin, H]]
+[[Category: Qin H]]
-[[Category: Wang, W]]
+[[Category: Wang W]]
-[[Category: Fat10]]
-[[Category: Protein binding]]

2mbe

From Proteopedia

Revision as of 06:30, 2 March 2023

Backbone 1H and 15N Chemical Shift Assignments for the first domain of FAT10

Structural highlights

Function

Publication Abstract from PubMed

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox